AMINOCAPROIC ACID IN THE CONTROL OF HÆMORRHAGE AFTER PROSTATECTOMY: Safety of Aminocaproic Acid—a Controlled Trial
- 29 January 1966
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 287 (7431), 232-234
- https://doi.org/10.1016/s0140-6736(66)90052-3
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- AMINOCAPROIC ACID IN THE CONTROL OF HÆMORRHAGE AFTER PROSTATECTOMY: A Controlled TrialThe Lancet, 1966
- The Use of Epsilon Amino Caproic Acid in the Control of Hematuria Associated with HemoglobinopathiesJournal of Urology, 1965
- ε-AMINOCAPROIC ACID AND OTHER INHIBITORS OF FIBRINOLYSISBritish Medical Bulletin, 1964
- Effects of Epsilon Aminocaproic Acid on Coagulation and Fibrinolytic MechanismsJAMA, 1964
- Fibrinolytic mechanisms and the development of thrombolytic therapyThe American Journal of Medicine, 1962
- Thrombotic State after a Hemorrhagic Diathesis, a Possible Complication of Therapy with Epsilon-Aminocaproic AcidBlood, 1962
- Reduction of Postprostatectomy Bleeding by Epsilon-Aminocaproic AcidThe New England Journal of Medicine, 1962
- The Use of Epsilon Aminocaproic Acid, a Potent Inhibitor of Fibrinolytic Activity, in the Management of Postoperative HematuriaJournal of Urology, 1961
- Clinical Experiences with ε‐Aminocaproic Acid (ε‐ACA) as an Antifibrinolytic AgentActa Medica Scandinavica, 1961